https://stock.noler.com/us/stock/logicbio-therapeutics-inc https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accrued-insurance-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/logicbio-therapeutics-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/logicbio-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/logicbio-therapeutics-inc/aoci https://stock.noler.com/us/stock/logicbio-therapeutics-inc/area-of-real-estate-property https://stock.noler.com/us/stock/logicbio-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/logicbio-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/logicbio-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/logicbio-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/logicbio-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/logicbio-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/logicbio-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/logicbio-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/logicbio-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/logicbio-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/logicbio-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/logicbio-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/logicbio-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/logicbio-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/logicbio-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/logicbio-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/logicbio-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/logicbio-therapeutics-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/logicbio-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/logicbio-therapeutics-inc/current-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/logicbio-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-reserves https://stock.noler.com/us/stock/logicbio-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/logicbio-therapeutics-inc/depreciation https://stock.noler.com/us/stock/logicbio-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/logicbio-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/logicbio-therapeutics-inc/dividends-declared https://stock.noler.com/us/stock/logicbio-therapeutics-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/logicbio-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/eps https://stock.noler.com/us/stock/logicbio-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/logicbio-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/logicbio-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/logicbio-therapeutics-inc/foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/logicbio-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/logicbio-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/logicbio-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/logicbio-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/logicbio-therapeutics-inc/income-tax https://stock.noler.com/us/stock/logicbio-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/logicbio-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/logicbio-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/logicbio-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/logicbio-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/logicbio-therapeutics-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/logicbio-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/logicbio-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/logicbio-therapeutics-inc/lease-and-rental-expense https://stock.noler.com/us/stock/logicbio-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/logicbio-therapeutics-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/logicbio-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/logicbio-therapeutics-inc/liabilities-assumed https://stock.noler.com/us/stock/logicbio-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/logicbio-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/logicbio-therapeutics-inc/net-income https://stock.noler.com/us/stock/logicbio-therapeutics-inc/notes-payable https://stock.noler.com/us/stock/logicbio-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/logicbio-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-income https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/logicbio-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/other-income https://stock.noler.com/us/stock/logicbio-therapeutics-inc/other-liabilities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/logicbio-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/logicbio-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/logicbio-therapeutics-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/logicbio-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/logicbio-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/logicbio-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/logicbio-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-repayments-of-lines-of-credit https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/logicbio-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/logicbio-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/logicbio-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/logicbio-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/logicbio-therapeutics-inc/public-float https://stock.noler.com/us/stock/logicbio-therapeutics-inc/realized-gain-loss-on-marketable-securities-cost-method-investments-and-other-investments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/logicbio-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/logicbio-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/restricted-cash-current https://stock.noler.com/us/stock/logicbio-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/logicbio-therapeutics-inc/revenue https://stock.noler.com/us/stock/logicbio-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/logicbio-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/logicbio-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/logicbio-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/logicbio-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/logicbio-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/logicbio-therapeutics-inc/short-term-investments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/logicbio-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/logicbio-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/logicbio-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/logicbio-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/logicbio-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/logicbio-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/logicbio-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/logicbio-therapeutics-inc/total-assets https://stock.noler.com/us/stock/logicbio-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/logicbio-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/logicbio-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/logicbio-therapeutics-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/logicbio-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/logicbio-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted